1. Home
  2. LUNG vs KOPN Comparison

LUNG vs KOPN Comparison

Compare LUNG & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • KOPN
  • Stock Information
  • Founded
  • LUNG 1995
  • KOPN 1984
  • Country
  • LUNG United States
  • KOPN United States
  • Employees
  • LUNG N/A
  • KOPN N/A
  • Industry
  • LUNG Industrial Specialties
  • KOPN Semiconductors
  • Sector
  • LUNG Health Care
  • KOPN Technology
  • Exchange
  • LUNG Nasdaq
  • KOPN Nasdaq
  • Market Cap
  • LUNG 65.6M
  • KOPN 255.1M
  • IPO Year
  • LUNG 2020
  • KOPN 1992
  • Fundamental
  • Price
  • LUNG $1.70
  • KOPN $2.53
  • Analyst Decision
  • LUNG Buy
  • KOPN Strong Buy
  • Analyst Count
  • LUNG 7
  • KOPN 2
  • Target Price
  • LUNG $7.66
  • KOPN $2.63
  • AVG Volume (30 Days)
  • LUNG 574.6K
  • KOPN 3.3M
  • Earning Date
  • LUNG 10-29-2025
  • KOPN 11-11-2025
  • Dividend Yield
  • LUNG N/A
  • KOPN N/A
  • EPS Growth
  • LUNG N/A
  • KOPN N/A
  • EPS
  • LUNG N/A
  • KOPN N/A
  • Revenue
  • LUNG $90,549,000.00
  • KOPN $46,959,478.00
  • Revenue This Year
  • LUNG $10.30
  • KOPN N/A
  • Revenue Next Year
  • LUNG $14.72
  • KOPN $27.17
  • P/E Ratio
  • LUNG N/A
  • KOPN N/A
  • Revenue Growth
  • LUNG 18.24
  • KOPN 13.03
  • 52 Week Low
  • LUNG $1.47
  • KOPN $0.56
  • 52 Week High
  • LUNG $9.37
  • KOPN $2.67
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 43.79
  • KOPN 68.68
  • Support Level
  • LUNG $1.60
  • KOPN $2.05
  • Resistance Level
  • LUNG $1.80
  • KOPN $2.40
  • Average True Range (ATR)
  • LUNG 0.14
  • KOPN 0.19
  • MACD
  • LUNG 0.04
  • KOPN 0.03
  • Stochastic Oscillator
  • LUNG 36.67
  • KOPN 83.13

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About KOPN Kopin Corporation

Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.

Share on Social Networks: